STAT

Five ideas that might steer Gawande as CEO of Amazon-backed health company

Atul Gawande has yet to speak out about his plans for leading the new Amazon-JPMorgan-Berkshire Hathaway health care organization, but his past speeches and writings provide some clues to what he might do in the job.

Here are five key points about Gawande’s views:

He has thoughts about how to reduce health care costs. Lots of thoughts.

The purported goal of is to decrease health care costs for employees of the three corporate giants, though when it was announced, JPMorgan CEO Jamie Dimon said it could “create solutions that benefit … potentially all Americans.” (It should be noted that Dimon later tried to reassure spooked health care companies that the company’s purpose was really only for the three founding firms, as the Wall.)

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Novo Nordisk Deal, A Regeneron Setback, And More
Novo Nordisk agreed to acquire Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional cardiometabolic drug candidates.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…

Related Books & Audiobooks